| Dr Deborah A Sculco, MD | |
|
4950 State Highway 30, Cancer Medicine Center, Amsterdam, NY 12010-7520 | |
| (518) 770-7557 | |
| (518) 770-7558 |
| Full Name | Dr Deborah A Sculco |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 36 Years |
| Location | 4950 State Highway 30, Amsterdam, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013910660 | NPI | - | NPPES |
| 001319054 | Medicaid | CT | |
| 03380458 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 60470 (Georgia) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 259006 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Healthcare | Amsterdam, NY | Hospital |
| Nathan Littauer Hospital | Gloversville, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Mary's Healthcare | 7618960709 | 79 |
News Archive
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today announced the Europe, Middle East and Africa launch of the ATTUNE Revision Knee System, to complement the ATTUNE Primary Knee System and provide surgeons with a comprehensive solution for knee replacement. The ATTUNE Revision Knee System is being unveiled at the 19th European Federation of the National Associations of Orthopedics and Traumatology (EFORT) Congress, taking place in Barcelona, Spain.
By linking strings of spherical iron oxide nanoparticles and coating the resulting construct with a biocompatible polymer, a multi-institutional research team has created "nanoworms" that can better target tumors and produce stronger magnetic resonance imaging (MRI) signals than their component nanoparticles. The nanoworms also appear to be a promising vehicle for carrying anticancer drugs into tumors. The researchers published their work in the journal Advanced Materials.
› Verified 2 days ago
| Entity Name | St. Mary's Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518926401 PECOS PAC ID: 7618960709 Enrollment ID: O20040405001628 |
News Archive
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today announced the Europe, Middle East and Africa launch of the ATTUNE Revision Knee System, to complement the ATTUNE Primary Knee System and provide surgeons with a comprehensive solution for knee replacement. The ATTUNE Revision Knee System is being unveiled at the 19th European Federation of the National Associations of Orthopedics and Traumatology (EFORT) Congress, taking place in Barcelona, Spain.
By linking strings of spherical iron oxide nanoparticles and coating the resulting construct with a biocompatible polymer, a multi-institutional research team has created "nanoworms" that can better target tumors and produce stronger magnetic resonance imaging (MRI) signals than their component nanoparticles. The nanoworms also appear to be a promising vehicle for carrying anticancer drugs into tumors. The researchers published their work in the journal Advanced Materials.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deborah A Sculco, MD 4950 State Highway 30, Cancer Medicine Center, Amsterdam, NY 12010-7520 Ph: (518) 770-7557 | Dr Deborah A Sculco, MD 4950 State Highway 30, Cancer Medicine Center, Amsterdam, NY 12010-7520 Ph: (518) 770-7557 |
News Archive
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today announced the Europe, Middle East and Africa launch of the ATTUNE Revision Knee System, to complement the ATTUNE Primary Knee System and provide surgeons with a comprehensive solution for knee replacement. The ATTUNE Revision Knee System is being unveiled at the 19th European Federation of the National Associations of Orthopedics and Traumatology (EFORT) Congress, taking place in Barcelona, Spain.
By linking strings of spherical iron oxide nanoparticles and coating the resulting construct with a biocompatible polymer, a multi-institutional research team has created "nanoworms" that can better target tumors and produce stronger magnetic resonance imaging (MRI) signals than their component nanoparticles. The nanoworms also appear to be a promising vehicle for carrying anticancer drugs into tumors. The researchers published their work in the journal Advanced Materials.
› Verified 2 days ago
Nancy S Knudsen, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 427 Guy Park Ave, St Marys Hospital, Amsterdam, NY 12010 Phone: 518-842-1900 Fax: 518-841-7131 | |
Dr. Soo Gil Lee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5010 St Hwy 30, Ste 201, Amsterdam, NY 12010 Phone: 518-842-7161 Fax: 518-842-0797 | |
Karen Tedesco, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 Riverfront Ctr, Amsterdam, NY 12010 Phone: 518-843-0020 Fax: 518-843-0023 | |
Dr. Michael Finnegan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 425 Guy Park Ave, Suite 102, Amsterdam, NY 12010 Phone: 518-843-1240 | |
Jay Zimmerman, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 425 Guy Park Ave, Suite 102, Amsterdam, NY 12010 Phone: 518-843-1240 Fax: 518-843-0753 | |
Robert H Goslin, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1700 Riverfront Ctr, Amsterdam, NY 12010 Phone: 518-843-0020 Fax: 518-843-0023 |